Internal Medicine, Rheumatology · Asheville, NC
NPI
1538123989
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4 Vanderbilt Park Dr, Suite 200
Asheville, NC, 28803
Phone (828) 258-9533
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
194,908 services
Medicare patients, 2024
451
Average age 74
Drug cost, 2024
$4.1M
3,284 prescriptions
Company payments, 2025
$371
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ellison L Smith Jr. was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 68,800 times for 34 patients. In total Ellison L Smith Jr. billed 194,908 services in 94 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 68,800 | 34 | $3.61 | $248K |
| J3262 Injection, tocilizumab, 1 mg | Office | 34,200 | 15 | $4.65 | $159K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 25,300 | 46 | $9.06 | $229K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 12,525 | 39 | $33.80 | $423K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 11,970 | 22 | $8.56 | $102K |
| J0897 Injection, denosumab, 1 mg | Office | 6,180 | 73 | $20.23 | $125K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 5,910 | 17 | $23.08 | $136K |
| J9312 Injection, rituximab, 10 mg | Office | 2,550 | 13 | $61.22 | $156K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,122 | 25 | $0.09 | $101 |
| 82565 Clinical Chemistry | Office | 794 | 301 | $4.99 | $3,959 |
| 85025 Blood Count | Office | 755 | 279 | $7.54 | $5,693 |
| 86140 Clinical Chemistry | Office | 755 | 279 | $5.03 | $3,798 |
| 85652 Clinical Chemistry | Office | 754 | 279 | $2.63 | $1,984 |
| 80076 Clinical Chemistry | Office | 727 | 272 | $7.95 | $5,779 |
| 96372 Injection Administration | Office | 564 | 126 | $11.06 | $6,237 |
By year: 2022 $2.1M for 144,250 services; 2023 $2.1M for 180,510 services; 2024 $2.2M for 194,908 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82565 Clinical Chemistry | 794 | 301 | $4.99 | $3,959 |
| 85025 Blood Count | 755 | 279 | $7.54 | $5,693 |
| 86140 Clinical Chemistry | 755 | 279 | $5.03 | $3,798 |
| 85652 Clinical Chemistry | 754 | 279 | $2.63 | $1,984 |
| 80076 Clinical Chemistry | 727 | 272 | $7.95 | $5,779 |
| 36415 Venipuncture Blood Collection | 451 | 198 | $8.60 | $3,877 |
| 82310 Clinical Chemistry | 141 | 96 | $5.06 | $713 |
| 86481 Immunoassay | 115 | 114 | $98.00 | $11K |
| 86160 Immunoassay | 104 | 30 | $11.76 | $1,223 |
| 82306 Clinical Chemistry | 73 | 73 | $29.01 | $2,118 |
Medicare prescription drug claims, 2024
In 2024, the drug Ellison L Smith Jr. prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 571 prescriptions and refills. In total Ellison L Smith Jr. wrote 3,284 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 571 | 1,243 | 131 | $16K |
| Hydroxychloroquine Sulfate Generic | 564 | 1,410 | 152 | $23K |
| Prednisone Generic | 274 | 380 | 84 | $1,950 |
| Alendronate Sodium Generic | 141 | 387 | 46 | $1,281 |
| Sulfasalazine Generic | 135 | 317 | 36 | $5,488 |
| Enbrel Sureclick Etanercept | 101 | 104 | 11 | $845K |
| Leflunomide Generic | 89 | 247 | 24 | $3,810 |
| Simponi Golimumab | 76 | 76 | Under 11 | $468K |
| Duloxetine Hcl Generic | 74 | 162 | 18 | $1,565 |
| Mycophenolate Mofetil Generic | 71 | 146 | 17 | $11K |
| Xeljanz Xr Tofacitinib Citrate | 67 | 67 | Under 11 | $391K |
| Humira(Cf) Pen Adalimumab | 66 | 66 | Under 11 | $601K |
| Meloxicam Generic | 64 | 175 | 21 | $386 |
| Celecoxib Generic | 57 | 126 | 15 | $1,623 |
| Leucovorin Calcium Generic | 55 | 144 | 14 | $1,075 |
Brand drugs: - claims; generic drugs: 2,575 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ellison L Smith Jr. $371 ($371 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $130.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.